Antimicrobial resistance in the 1990s

Infectious Diseases in Clinical Practice

Volumn 5, Issue SUPPL. 1, 1996, Pages

  Gorbach, Sherwood L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; METICILLIN; MINOCYCLINE; NOVOBIOCIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TRIAZOLE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CANDIDA; CONFERENCE PAPER; ENTEROCOCCUS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOSIS; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0029873854     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. American Society for Microbiology, Public Scientific Affairs Board. Report of the ASM Task Force on Antibiotic Resistance. Washington (DC): American Society for Microbiology, 1995.
2. McCraig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-9.
3. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. Lancet 1994;330:1247-51.
4. Swartz MN. Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci USA 1994;91:2420-7.
5. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-42.
6. Rosenberg J. Methicillin-rcsistant Staphylococcus aureus (MRSA) in the community: who's watching? Lancet 1995; 346:132-3.
7. Layton MC, Hierholzer WJ, Patterson JE. The evolving epidemiology of methicillin-resistant Staphylococcus anreus at a university hospital. Infect Control Hosp Epidemiol 1995;16:12-7.
8. Acar JF, Carlet J, Fourrier A, Goldstein FW. Rapid increase of methicillin and fluoroquinolone resistance in S. aureus during a 6-year period [abstract A51]. Poster paper presented at the 3rd Decennial International Conference on Nosocomial Infectons; July 31-Aug 3, 1990; Atlanta (GA).
9. Blumberg HM, Rimloand D, Carroll DJ, Terry P, Wachsmuth IK. Rapid develpment of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 1991;163:1279-85.
10. Zervos MJ, Dembry L. Enterococcus in surgical infections: virulence, epidemiology, and resistance. Infect Dis Clin Pract 1994;3(Suppl):14S-20S.
11. Coque TM, Patterson JE, Steckelberg JM, Murray BE. J Infect Dis 1995;171:1223-9.
12. Handwerger S, Rauncher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-5.
13. Hoge CW, Adams J, Buchanan B, Sears SD. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis 1991;13:1600-5.
14. Bartlett JG. IDCP snapshots: vancomycin-resistant enterococci at Johns Hopkins. Infect Dis Clin Pract 1996;5:1-2.
15. Austin R. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis 1981;3(1 Suppl):1S-17S.
16. Spika JS, Facklam RR, Plikaytis BD, et al. Antimicrobial resistance of Streptococcus pneumoniae in the United States. J Infect Dis 1991;163:1273-8.
17. Centers for Disease Control and Prevention. Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee. 1993. MMWR Morb Mortal Wkly Rep 1994;43:23-5.
18. Wenzel RP, Pfaller MA. Candida species: emerging hospital bloodstream pathogens [editorial]. Infect Control Hosp Epidemiol 1991;12:523-4.
19. Wenzel RP. Epidemiology of nosocomial Candida infections. Infect Dis Clin Pract 1994;3(2 Suppl):56S-59S.
20. Walsh TJ. Evolving patterns of nosocomial and community-acquired deep mycoses: analogies to other infections and implications for practitioners. Infect Dis Clin Pract 1994;3(2 Suppl):103S-112S.
21. Dick JD, Rosenguard BR, Merz WG, et al. Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii. Ann Intern Med 1985;102:67-8.
22. Merz WG. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol 1984;20:1194-5.